Iowans rally for statewide marijuana legalization
Marijuana advocates meet at Des Moines City Hall on Saturday and march down Locust Street to the Iowa Capitol.(Photo: Linh Ta/The Register)Buy Photo
The daily pills 39-year-old Angel Francis-Kline has to take makes it hard for her to handle everyday life.
In a day, she can take between 12 to 16 pills to deal with her fibromyalgia, osteoarthritis, post-traumatic stress disorder, insomnia and early on-set menopause. The combination of her pills, like Cymbalta and Hydrocodone make her uncontrollably shake and have seizures, causing dangerous situations, especially when she's driving.
"It's living everyday in pain," Francis-Kline. said. "What they're making me take is poison."
One evening, after taking a hit of hash oil concentrate, commonly known as a "dab," Francis-Kline said she safely drove back home, felt no pain for over six hours and was able to fall asleep around midnight rather than the usual 3 a.m.
That's why she, along...
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.